We work to map the microbiome and illuminate interactions foundational to the health of humanity.
Location: United States, New Jersey, South Brunswick
Employees: 1-10
Total raised: $24.5M
Founded date: 2020
Investors 3
| Date | Name | Website |
| 06.03.2023 | DCVC | dcvc.com/ |
| 30.08.2022 | Kevin M. M... | mcgovernce... |
| 28.07.2024 | Germin8 Ve... | germin8ven... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 01.07.2024 | - | $12.5M | - |
| 22.06.2023 | Seed | $12M | Uncommon D... |
Mentions in press and media 8
| Date | Title | Description |
| 04.07.2024 | Kanvas Biosciences: Revolutionizing Cancer Treatment with Microbiome-Based Therapies | Kanvas Biosciences, a cutting-edge spatial biology company based in Princeton, NJ, has recently secured an additional $12.5 million in funding to advance its groundbreaking microbiome-based immuno-oncology drug candidates. This latest fundi... |
| 01.07.2024 | Kanvas Biosciences Secures Additional $12.5M to Advance Its Novel, Microbiome-Based Immuno-oncology Drug Candidates to IND Filing | With $29.5 million in total funding, the company has developed the world's leading spatial biology platform, designed for breakthroughs in drug development, clinical diagnostics, agriculture, and food safety. This proprietary mapping techno... |
| 01.07.2024 | Kanvas Biosciences Secures Additional $12.5M in Funding | Kanvas Biosciences, Princeton, NJ-based spatial biology company, raised additional $12.5M in funding. The round, which brought the total amount to $29.5M, was led by DCVC and Lions Capital LLC, and participation from FemHealth Ventures, Ger... |
| 22.06.2023 | Kanvas Biosciences Raises $12M in Pre-Series A | Kanvas Biosciences, a Monmouth Junction, NJ-based company which specializes in advancing microbiome mapping technology, raised $12M in Pre-Series A funding. The round was led by DCVC with participation from Lions Capital LLC, Cooke LLC, Unc... |
| 22.06.2023 | Kanvas Biosciences Inks $12M Series A Round | PRINCETON, NJ, Kanvas Biosciences, the leader in microbiome mapping technology, announced today a $12 million Pre-Series A funding round. >> Click here for more funding data on Kanvas Biosciences >> To export Kanvas Bioscien... |
| - | Kanvas Biosciences | “Kanvas Biosciences has developed cutting-edge imaging technology to map the microbiome and develop therapeutics.” |
| - | Kanvas Biosciences | “Kanvas Biosciences has developed cutting-edge imaging technology to map the microbiome and develop therapetucis.” |
| - | Kanvas Biosciences | “Kanvas Biosciences” |